A phase I/II study of talazoparib and axitinib in patients with advanced clear cell renal cell carcinoma Meeting Abstract
| Authors: | Kotecha, R. R.; Doshi, S. D.; Knezevic, A.; Jacobi, R.; Aggen, D. H.; McHugh, D. J.; Shah, N. J.; Carlo, M. I.; Keegan, N. M.; Gayadin, Y.; Chaim, J.; Feldman, D. R.; Motzer, R. J.; Voss, M. H. |
| Abstract Title: | A phase I/II study of talazoparib and axitinib in patients with advanced clear cell renal cell carcinoma |
| Meeting Title: | 2024 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 42 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2024 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2024-06-01 |
| Language: | English |
| ACCESSION: | WOS:001275557401186 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2024.42.16_suppl.4541 |
| Notes: | Meeting Abstract: 4541 -- Source: Wos |
